A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use

BACKGROUND: Many HIV patients receiving antiretroviral treatment develop lipodystrophy. NEW-FILL(®) is a polylactic acid injected to treat facial lipoatrophy. The objectives of this study were to describe (1) change in quality of life (QoL) of HIV patients treated with NEW-FILL(®) in the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Duracinsky, Martin, Leclercq, Pascale, Armstrong, Andrew Richard, Dolivo, Marc, Mouly, Frédéric, Chassany, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598243/
https://www.ncbi.nlm.nih.gov/pubmed/23425246
http://dx.doi.org/10.1186/1471-2334-13-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598243/
https://www.ncbi.nlm.nih.gov/pubmed/23425246
http://dx.doi.org/10.1186/1471-2334-13-92

Ejemplares similares